TheraNews
Subscribe

Archive summary

U.S. cancer survivor ranks grow as detection rises and deaths drop

More Americans are living with cancer as death rates continue to decline, thanks to improved detection methods and better treatment options,

Summary of reporting by dailybreeze 2 min read Markdown

The American Cancer Society’s annual report shows significant progress in cancer survival rates. Seven out of 10 people survived for five years after diagnosis during 2015-2021 across all cancer types, a key therapeutic goal. Improvements extended to more aggressive cancers, with higher survival rates for myeloma, liver, and lung cancers compared with decades prior.

Approximately 18 million people are now living with cancer in the United States, with 9 million diagnosed in the past decade. Overall cancer mortality has declined by 34% since its peak in 1991. In 2023, more than 3 million Americans died from cancer, down more than 188,000 from the prior year. However, fatality rates are rising for some common cancers including breast, prostate, oral cavity, and pancreatic cancers. Cancer remains the second leading cause of death overall, but for men ages 60-79 and women ages 40-79, it is the leading killer.

The nonprofit research organization predicted more than 2.1 million new diagnoses in 2026, with more than 600,000 deaths expected. Lung, colorectal, and pancreatic tumors are anticipated to be the three leading causes of cancer death. Breast cancer is the dominant diagnosis for women and is the leading cause of cancer death among women younger than 50, with Black women most likely to die after a breast cancer diagnosis. In the past decade, breast cancer rates have increased by about 1% each year, with faster growth in women under 50. Lower fertility rates, higher obesity prevalence, alcohol consumption, and lower physical activity contribute to this trend.

While improved early detection methods and better treatments have driven survival advances, the high cost of new cancer drugs presents barriers. The median initial price of cancer drugs has quadrupled to $25,000 a month, and fewer than half approved since 2000 have been shown to prolong people’s lives. Concerns about healthcare access and funding cuts could reverse progress and stall future breakthroughs.


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.dailybreeze.com/2026/01/13/us-cancer-survivor-ranks-grow-as-detection-rises-and-deaths-drop/

Original report

U.S. cancer survivor ranks grow as detection rises and deaths drop
dailybreeze

About this article

  • Educational, not advice. Nothing here is medical, legal, billing or financial advice. Clinical decisions belong with a licensed clinician; coverage and legal questions belong with the payer, the statute or counsel. Prices and rates change; confirm them with the provider and the plan.
  • Corrections. If something on this page is wrong, send a correction with the source.

Topics: mental-health

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.